Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-17

FDA Approved: MICAFUNGIN — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approves Fresenius Kabi USA, LLC's original ANDA for micafungin sodium (Micafungin), a generic echinocandin antifungal. The approval covers the same labeled…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Micafungin (micafungin)

Snippet

ORIG AP for MICAFUNGIN (MICAFUNGIN SODIUM)